• AstraZeneca PLC (AZN) Throws a $4 Billion Bid at Amylin Pharmaceuticals, Inc. (AMLN) More...
• Flagship Biosciences LLC Acquires IHCtech, a Leading Provider of Research Immunohistochemistry and Histology Services More...
• Hi-Tech Pharmacal (HITK) Acquires Cormax Brand Rights from Watson Laboratories, Inc. (WPI) for Undisclosed Amount More...
• Orexo AB Acquires All US Rights for ProStrakan Group's Abstral and Receives a Net Cash Consideration of £55 Million More...
• Alize Pharma Closes EUR 3.3 Million Funding Round More...
• Emergent BioSolutions (EBS) Secures Additional Funding from Biomedical Advanced Research and Development Authority (BARDA) to Pursue Post-Exposure Prophylaxis Indication for BioThrax More...
• AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million More...
• Astellas Pharma Inc. (YPH.BE) and Drais Pharmaceuticals Partner to Develop Second Astellas Compound Through Seldar More...
• Baxter International, Inc. (BAX) Announces Collaboration with Chatham Therapeutics for Factor IX Hemophilia B Gene Therapy Treatment More...
• New Agreements to Give Quintiles, Inc. (QTRN) Access to De-Identified EMR Data Representing 40 Million Patient Lives More...
• Nouveau Life Pharmaceuticals (NOUV) Announces New CEO More...
• Codexis, Inc. (CDXS) Appoints John J. Nicols as President and Chief Executive Officer More...
• Targacept, Inc. (TRGT)'s Chief Executive deBethizy Steps Down in Shake-Up More...
• Apricus Biosciences (APRI) Announces Appointment of Paul V. Maier to Its Board of Directors More...
• Anacor Pharmaceuticals, Inc. Appoints Paul L. Berns to Its Board of Directors More...
• Simulations Plus (SLP) Reports Preliminary Third Quarter FY2012 Results More...
• GenScript Corporation Completes $40 Million R&D Center in Nanjing More...
• New Roche (RHHBY) Drug Slows Breast Tumor Growth More...
• Bristol-Myers Squibb Company (BMY) Immune Drug Shows Promise in Three Cancers, Success May Spur Industry Race More...
• Johnson & Johnson (JNJ) Prostate Cancer Drug So Effective Trial Stopped More...
• Bayer AG (BAY.F) Drug Stalls Stomach Tumors After Standard Treatment More...
• GlaxoSmithKline (GSK) Melanoma Drugs Beat Chemo in Pivotal Trials More...
• FDA Asked to Ban Lice Shampoo for Kids More...
• FivePrime Therapeutics, Inc. Announces That Human Genome Sciences Files U.S. IND for HGS1036/FP-1039 FGF Ligand Trap More...
• Premature Babies May Have Increased Risk of Psychosis, Archives of General Psychiatry Reveals More...
• Open-Fire Cooking May Affect Child Cognitive Development, University of California, Riverside Study More...
• University of Maryland Medical Center Study Questions Fruit Sugar Role in Hypertension More...
• More Vitamin D Might Help Older People Stay Active, Wake Forest University School of Medicine Study More...
• Antidepressant Helps Relieve Pain From Chemotherapy, University of Michigan School of Nursing Study More...
• Flagship Biosciences LLC Acquires IHCtech, a Leading Provider of Research Immunohistochemistry and Histology Services More...
• Hi-Tech Pharmacal (HITK) Acquires Cormax Brand Rights from Watson Laboratories, Inc. (WPI) for Undisclosed Amount More...
• Orexo AB Acquires All US Rights for ProStrakan Group's Abstral and Receives a Net Cash Consideration of £55 Million More...
• Alize Pharma Closes EUR 3.3 Million Funding Round More...
• Emergent BioSolutions (EBS) Secures Additional Funding from Biomedical Advanced Research and Development Authority (BARDA) to Pursue Post-Exposure Prophylaxis Indication for BioThrax More...
• AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million More...
• Astellas Pharma Inc. (YPH.BE) and Drais Pharmaceuticals Partner to Develop Second Astellas Compound Through Seldar More...
• Baxter International, Inc. (BAX) Announces Collaboration with Chatham Therapeutics for Factor IX Hemophilia B Gene Therapy Treatment More...
• New Agreements to Give Quintiles, Inc. (QTRN) Access to De-Identified EMR Data Representing 40 Million Patient Lives More...
• Nouveau Life Pharmaceuticals (NOUV) Announces New CEO More...
• Codexis, Inc. (CDXS) Appoints John J. Nicols as President and Chief Executive Officer More...
• Targacept, Inc. (TRGT)'s Chief Executive deBethizy Steps Down in Shake-Up More...
• Apricus Biosciences (APRI) Announces Appointment of Paul V. Maier to Its Board of Directors More...
• Anacor Pharmaceuticals, Inc. Appoints Paul L. Berns to Its Board of Directors More...
• Simulations Plus (SLP) Reports Preliminary Third Quarter FY2012 Results More...
• GenScript Corporation Completes $40 Million R&D Center in Nanjing More...
• New Roche (RHHBY) Drug Slows Breast Tumor Growth More...
• Bristol-Myers Squibb Company (BMY) Immune Drug Shows Promise in Three Cancers, Success May Spur Industry Race More...
• Johnson & Johnson (JNJ) Prostate Cancer Drug So Effective Trial Stopped More...
• Bayer AG (BAY.F) Drug Stalls Stomach Tumors After Standard Treatment More...
• GlaxoSmithKline (GSK) Melanoma Drugs Beat Chemo in Pivotal Trials More...
• FDA Asked to Ban Lice Shampoo for Kids More...
• FivePrime Therapeutics, Inc. Announces That Human Genome Sciences Files U.S. IND for HGS1036/FP-1039 FGF Ligand Trap More...
• Premature Babies May Have Increased Risk of Psychosis, Archives of General Psychiatry Reveals More...
• Open-Fire Cooking May Affect Child Cognitive Development, University of California, Riverside Study More...
• University of Maryland Medical Center Study Questions Fruit Sugar Role in Hypertension More...
• More Vitamin D Might Help Older People Stay Active, Wake Forest University School of Medicine Study More...
• Antidepressant Helps Relieve Pain From Chemotherapy, University of Michigan School of Nursing Study More...
0 comments